Last reviewed · How we verify
Ferrous Gluconate 300 MG
At a glance
| Generic name | Ferrous Gluconate 300 MG |
|---|---|
| Also known as | (Ferrous-Gluconate®, tab.300mg glucofer, Egypt |
| Sponsor | National and Kapodistrian University of Athens |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Iron Prehabilitation in Endometrial Cancer (PHASE4)
- Lactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During Pregnancy (PHASE4)
- Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment (PHASE2)
- Safe and Efficacious Iron for Children in Kenya (PHASE2, PHASE3)
- Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ferrous Gluconate 300 MG CI brief — competitive landscape report
- Ferrous Gluconate 300 MG updates RSS · CI watch RSS
- National and Kapodistrian University of Athens portfolio CI